Traws Pharma Financials
| TRAW Stock | 5.02 0.31 5.82% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.92 | 2.4577 |
|
|
The essential information of the day-to-day investment outlook for Traws Pharma includes many different criteria found on its balance sheet. An individual investor should monitor Traws Pharma's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Traws Pharma.
Net Income |
|
Traws | Select Account or Indicator |
Please note, the imprecision that can be found in Traws Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Traws Pharma. Check Traws Pharma's Beneish M Score to see the likelihood of Traws Pharma's management manipulating its earnings.
Traws Pharma Stock Summary
Traws Pharma competes with Analog Devices, HE Equipment, Loandepot, China Aircraft, and Hertz Global. Traws Pharma is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| CUSIP | 68232V108 68232V405 68232V801 68232V306 68232V884 |
| Older Symbol | ONTX |
| Location | Pennsylvania; U.S.A |
| Business Address | 12 Penns Trail, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.trawspharma.com |
| Phone | 267 759 3680 |
Traws Pharma Key Financial Ratios
| Return On Equity | -10.97 | ||||
| Operating Margin | (103.23) % | ||||
| Price To Sales | 39.17 X | ||||
| Revenue | 226 K | ||||
| EBITDA | (20.28 M) |
Traws Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Traws Pharma's current stock value. Our valuation model uses many indicators to compare Traws Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Traws Pharma competition to find correlations between indicators driving Traws Pharma's intrinsic value. More Info.Traws Pharma is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . At this time, Traws Pharma's Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Traws Pharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Traws Pharma Systematic Risk
Traws Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Traws Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Traws Pharma correlated with the market. If Beta is less than 0 Traws Pharma generally moves in the opposite direction as compared to the market. If Traws Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Traws Pharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Traws Pharma is generally in the same direction as the market. If Beta > 1 Traws Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Traws Pharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Traws Pharma's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Traws Pharma growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Traws Pharma December 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Traws Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Traws Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Traws Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Traws Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Traws Pharma's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 21.25 | |||
| Value At Risk | (8.30) | |||
| Potential Upside | 7.87 |
Additional Tools for Traws Stock Analysis
When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.